Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INFU InfuSystem	$9.57 -0.4%	$6.79	$4.61 ▼ $9.97	$196.29M	1.81	168,396 shs	167,703 shs
INGN Inogen	$7.75 +2.9%	$6.90	$5.70 ▼ $13.33	$209.56M	1.72	278,029 shs	203,437 shs
PROF Profound Medical	$4.74 +3.0%	$5.73	$3.89 ▼ $9.38	$142.45M	0.52	157,755 shs	62,228 shs
ZYXI Zynex	$1.66 +8.5%	$2.14	$1.23 ▼ $9.42	$50.29M	0.91	550,173 shs	162,872 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INFU InfuSystem	-0.42%	-0.62%	+60.57%	+76.89%	+38.70%
INGN Inogen	+2.92%	+3.89%	+15.16%	+18.68%	-37.85%
PROF Profound Medical	+3.04%	+11.53%	-18.70%	-7.60%	-50.11%
ZYXI Zynex	+8.50%	+9.21%	-33.60%	-30.54%	-78.53%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INFU InfuSystem	3.7365 of 5 stars	2.0	5.0	0.0	3.9	4.2	1.9
INGN Inogen	4.342 of 5 stars	3.3	5.0	3.9	2.2	1.7	0.6
PROF Profound Medical	1.6033 of 5 stars	3.5	1.0	0.0	1.2	0.8	0.6
ZYXI Zynex	2.4893 of 5 stars	3.2	1.0	0.0	1.9	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INFU InfuSystem	4.00	Strong Buy	$12.50	30.62% Upside
INGN Inogen	2.50	Moderate Buy	$11.00	41.94% Upside
PROF Profound Medical	3.00	Buy	$11.00	132.07% Upside
ZYXI Zynex	2.33	Hold	$4.90	195.18% Upside

Current Analyst Ratings Breakdown

Latest ZYXI, INFU, INGN, and PROF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/1/2025	ZYXI Zynex	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$3.70
8/1/2025	ZYXI Zynex	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
7/22/2025	INFU InfuSystem	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$12.00
7/21/2025	INFU InfuSystem	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/15/2025	ZYXI Zynex	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$4.00 ➝ $3.00
6/30/2025	ZYXI Zynex	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$8.00
6/16/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/15/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INFU InfuSystem	$139.89M	1.40	$0.75 per share	12.79	$2.47 per share	3.87
INGN Inogen	$335.70M	0.62	N/A	N/A	$7.38 per share	1.05
PROF Profound Medical	$10.68M	13.34	N/A	N/A	$1.31 per share	3.62
ZYXI Zynex	$192.35M	0.26	$0.24 per share	6.80	$0.04 per share	41.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INFU InfuSystem	$870K	$0.23	159.53	30.87	N/A	1.12%	2.78%	1.41%	N/A
INGN Inogen	-$35.89M	-$1.06	N/A	N/A	N/A	-7.58%	-13.77%	-8.52%	11/6/2025 (Estimated)
PROF Profound Medical	-$27.82M	-$1.46	N/A	N/A	N/A	-343.97%	-89.74%	-73.06%	11/6/2025 (Estimated)
ZYXI Zynex	$2.99M	-$0.94	N/A	3.53	N/A	-19.79%	-78.54%	-16.70%	10/30/2025 (Estimated)

Latest ZYXI, INFU, INGN, and PROF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q2 2025	PROF Profound Medical	-$0.43	-$0.52	-$0.09	-$0.52	$4.75 million	$2.21 million
8/7/2025	Q2 2025	INGN Inogen	-$0.22	-$0.15	+$0.07	-$0.15	$90.40 million	$92.28 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INFU InfuSystem	N/A	N/A	N/A	N/A	N/A
INGN Inogen	N/A	N/A	N/A	N/A	N/A
PROF Profound Medical	N/A	N/A	N/A	N/A	N/A
ZYXI Zynex	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INFU InfuSystem	0.50	1.98	1.59
INGN Inogen	N/A	3.03	2.67
PROF Profound Medical	0.11	8.53	10.03
ZYXI Zynex	0.56	0.62	0.45

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INFU InfuSystem	71.13%
INGN Inogen	89.94%
PROF Profound Medical	47.86%
ZYXI Zynex	29.68%

Insider Ownership

Company	Insider Ownership
INFU InfuSystem	11.40%
INGN Inogen	1.46%
PROF Profound Medical	1.52%
ZYXI Zynex	49.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INFU InfuSystem	410	20.43 million	19.10 million	Optionable
INGN Inogen	1,030	27.04 million	26.65 million	Optionable
PROF Profound Medical	150	30.05 million	29.60 million	Optionable
ZYXI Zynex	770	30.30 million	15.37 million	Optionable

ZYXI, INFU, INGN, and PROF Headlines

Recent News About These Companies

Contrasting Zynex (NASDAQ:ZYXI) & United Health Products (OTCMKTS:UEEC)

August 20 at 2:55 AM | americanbankingnews.com

Zynex announces new executive team

August 18, 2025 | msn.com

Zynex welcomes Steve Dyson as CEO, adds to leadership team

August 18, 2025 | proactiveinvestors.com

Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles

August 18, 2025 | prnewswire.com

Zynex, Inc. Investors: Company Investigated by the Portnoy Law Firm

August 14, 2025 | globenewswire.com

ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

August 13, 2025 | globenewswire.com

Zynex Q2 Revenue Drops 55%

August 5, 2025 | fool.com

Zynex Inc. Faces Challenges Amid Strategic Shifts

August 4, 2025 | theglobeandmail.com

Zynex (NASDAQ:ZYXI) Raised to "Buy" at LADENBURG THALM/SH SH

August 2, 2025 | marketbeat.com

Zynex (NASDAQ:ZYXI) Rating Lowered to "Neutral" at HC Wainwright

August 2, 2025 | marketbeat.com

Zynex, Inc. (NASDAQ:ZYXI) Q2 2025 Earnings Call Transcript

August 1, 2025 | msn.com

HC Wainwright & Co. Downgrades Zynex (ZYXI)

August 1, 2025 | msn.com

Zynex, Inc.: Zynex Reports Second Quarter 2025 Financial Results

August 1, 2025 | finanznachrichten.de

Zynex Inc (ZYXI) Q2 2025 Earnings Report Preview: What to Look For

August 1, 2025 | finance.yahoo.com

Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript

July 31, 2025 | seekingalpha.com

Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates

July 31, 2025 | zacks.com

Zynex eyes growth revival under new CEO, advances oximeter technology

July 31, 2025 | proactiveinvestors.com

Zynex Reports Second Quarter 2025 Financial Results

July 31, 2025 | prnewswire.com

Zynex Sets Second Quarter 2025 Earnings Call

July 22, 2025 | prnewswire.com

Zynex: New CEO Steven Dyson shares his vision â€“ ICYMI

July 12, 2025 | proactiveinvestors.com

Zynex: New CEO Steven Dyson shares his vision – ICYMI

July 12, 2025 | proactiveinvestors.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ZYXI, INFU, INGN, and PROF Company Descriptions

InfuSystem NYSE:INFU

$9.57 -0.04 (-0.42%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$9.57 0.00 (0.00%)

As of 08/22/2025 05:40 PM Eastern

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Inogen NASDAQ:INGN

$7.75 +0.22 (+2.92%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$7.75 0.00 (0.00%)

As of 08/22/2025 04:10 PM Eastern

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Profound Medical NASDAQ:PROF

$4.74 +0.14 (+3.04%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$4.76 +0.01 (+0.32%)

As of 08/22/2025 04:10 PM Eastern

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Zynex NASDAQ:ZYXI

$1.66 +0.13 (+8.50%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$1.65 -0.01 (-0.54%)

As of 08/22/2025 07:00 PM Eastern

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time